Literature DB >> 18418477

Ode to oseltamivir and amantadine?

Jm Conly1, Bl Johnston.   

Abstract

Entities:  

Year:  2006        PMID: 18418477      PMCID: PMC2095051          DOI: 10.1155/2006/106989

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  23 in total

Review 1.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

Review 2.  Neuraminidase inhibitors for influenza.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

3.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Scott A Harper; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; Carolyn B Bridges
Journal:  MMWR Recomm Rep       Date:  2005-07-29

4.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

5.  Respiratory virus surveillance. FluWatch project, 1997-1998.

Authors:  P Buck; S Herman; C Scott; B Winchester; P Zabchuk; P Sockett; M Vanderkloot
Journal:  Can Commun Dis Rep       Date:  1998-03-15

6.  Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts.

Authors:  J M Katz; W Lim; C B Bridges; T Rowe; J Hu-Primmer; X Lu; R A Abernathy; M Clarke; L Conn; H Kwong; M Lee; G Au; Y Y Ho; K H Mak; N J Cox; K Fukuda
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

7.  Oral oseltamivir treatment of influenza in children.

Authors:  R J Whitley; F G Hayden; K S Reisinger; N Young; R Dutkowski; D Ipe; R G Mills; P Ward
Journal:  Pediatr Infect Dis J       Date:  2001-02       Impact factor: 2.129

Review 8.  Pandemic threat posed by avian influenza A viruses.

Authors:  T Horimoto; Y Kawaoka
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

9.  Update: isolation of avian influenza A(H5N1) viruses from humans--Hong Kong, 1997-1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-01-09       Impact factor: 17.586

Review 10.  Antivirals for influenza in healthy adults: systematic review.

Authors:  T Jefferson; V Demicheli; D Rivetti; M Jones; C Di Pietrantonj; A Rivetti
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

View more
  6 in total

1.  A new self-attenuated therapeutic influenza vaccine that uses host cell-restricted attenuation by artificial microRNAs.

Authors:  Ke Wen; Haiyan Wang; Yanping Chen; Huixiao Yang; Zhichao Zheng; Yongyong Yan; Adilene Realivazquez Pena; Mingtao Zeng
Journal:  Int J Pharm       Date:  2021-12-06       Impact factor: 5.875

2.  Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.

Authors:  Abhijeet Bakre; Lauren E Andersen; Victoria Meliopoulos; Keegan Coleman; Xiuzhen Yan; Paula Brooks; Jackelyn Crabtree; S Mark Tompkins; Ralph A Tripp
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

3.  MicroRNA regulation of human protease genes essential for influenza virus replication.

Authors:  Victoria A Meliopoulos; Lauren E Andersen; Paula Brooks; Xiuzhen Yan; Abhijeet Bakre; J Keegan Coleman; S Mark Tompkins; Ralph A Tripp
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

4.  MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication.

Authors:  Stefan Wolf; Weilin Wu; Cheryl Jones; Olivia Perwitasari; Suresh Mahalingam; Ralph A Tripp
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

5.  Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment.

Authors:  Stefan Wolf; Scott Johnson; Olivia Perwitasari; Suresh Mahalingam; Ralph A Tripp
Journal:  Clin Transl Immunology       Date:  2017-03-31

6.  Protective Effect of Flavonoids from Ohwia caudata against Influenza a Virus Infection.

Authors:  Eun Bin Kwon; Hye Jin Yang; Jang-Gi Choi; Wei Li
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.